A student observes a change in cAMP during an experiment on cell communication. Which conclusion is most supported by this observation?

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

Cyclic adenosine monophosphate (cAMP) serves as a second messenger in eukaryotic signal transduction, relaying information from extracellular ligand–receptor binding events to intracellular effector proteins. The production of cAMP begins when a signaling molecule—such as epinephrine, glucagon, or a peptide hormone—binds to a G protein-coupled receptor (GPCR) embedded in the plasma membrane. This binding induces a conformational shift in the receptor's seven-transmembrane α-helical domains, enabling the receptor's intracellular loops to contact the heterotrimeric G protein (Gs). Upon activation, the Gα subunit releases GDP and binds GTP, causing it to dissociate from the Gβγ dimer. The liberated Gα-GTP complex migrates along the inner leaflet of the membrane and activates adenylate cyclase, a membrane-associated enzyme that converts ATP into cAMP by forming a phosphodiester bond between the 3′ and 5′ hydroxyl groups of the ribose sugar, releasing pyrophosphate.

Why Other Options Are Wrong

Once synthesized, cAMP diffuses through the cytosol and binds to the regulatory (R) subunits of protein kinase A (PKA). Each R subunit contains a cAMP-binding domain with positively charged residues that form ionic interactions with the negatively charged phosphate groups on cAMP. When four molecules of cAMP bind (two per R subunit), the R subunits undergo a conformational change that releases the catalytic (C) subunits. The free C subunits phosphorylate serine and threonine residues on downstream target proteins—including transcription factors like CREB (cAMP response element-binding protein)—thereby altering gene expression, metabolic enzyme activity, or ion channel permeability. The cell tightly regulates cAMP concentration through the opposing action of phosphodiesterases (PDEs), enzymes that hydrolyze cAMP into biologically inactive AMP. Any sustained deviation in cAMP levels therefore reflects an imbalance between adenylate cyclase activity and PDE-mediated degradation, which propagates through PKA-dependent phosphorylation cascades to modify cellular physiology.

PILLAR 2 — STEP-BY-STEP LOGIC

The question stem states that a student observes a change in cAMP during an experiment on cell communication. Because cAMP is an enzyme-regulated second messenger whose concentration depends on the GPCR–Gs–adenylate cyclase–PDE axis, an observable change cannot arise without a mechanistic cause. If adenylate cyclase activity increases or PDE activity decreases, cAMP accumulates; the converse reduces cAMP. Either scenario alters PKA-mediated phosphorylation of downstream substrates, modifying the cell's response to its external environment. When the experiment perturbs cell communication—perhaps by introducing a ligand, a receptor agonist or antagonist, or a toxin that targets G proteins—the resulting cAMP fluctuation signals that the signal transduction pathway has been activated, inhibited, or otherwise altered from its baseline state.

Option A states that the change indicates a disruption in normal cellular function that may affect the organism. This conclusion follows directly: cAMP operates within a narrow concentration range calibrated by evolution to produce appropriate physiological outputs (for example, epinephrine-triggered glycogenolysis in hepatocytes). Deviations from this range shift phosphorylation equilibria across dozens of substrates simultaneously, potentially disrupting metabolic homeostasis, gene expression profiles, and intercellular coordination. At the tissue and organismal level, such disruptions can impair processes like glucose regulation, cardiac contractility, or neural signaling—depending on which cell types are affected. Therefore, observing a cAMP change during a cell communication experiment provides evidence that cellular function has been perturbed in a manner that could have organismal consequences, which is the most scientifically defensible inference.

PILLAR 3 — DISTRACTOR ANALYSIS

Option B claims the cAMP change is likely due to random variation with no biological significance. This distractor exploits a common student tendency to attribute unexpected data to experimental noise. The critical flaw here is that cAMP is not a freely fluctuating metabolite—it is synthesized and degraded by specific enzymes whose activities are themselves controlled by receptor occupancy and allosteric regulation. Random variation sufficient to produce an observable cAMP shift would require uncontrolled fluctuations in adenylate cyclase or PDE activity, which cells suppress through compartmentalization and feedback mechanisms. The distractor reflects a misunderstanding of second-messenger regulation.

Option C suggests the experimental conditions are irrelevant to the system. This is contradicted by the observation itself: if conditions were irrelevant, no pathway component—including cAMP—would respond. A measurable cAMP change demonstrates that some variable in the experimental design (ligand concentration, inhibitor presence, receptor density) interacted with the signaling machinery. Students who select C may conflate a result they did not predict with a result that is irrelevant, failing to recognize that unpredicted responses often reveal the most informative biology.

Option D asserts that cAMP is unrelated to cell communication. This option requires outright denial of established molecular biology. Since Sutherland's discoveries in the 1950s and 1960s, cAMP has been recognized as the prototypical second messenger mediating intracellular responses to extracellular signals in organisms from bacteria to mammals. The distractor targets students who have not internalized the central role of second messengers in transducing receptor-level information into cytoplasmic and nuclear responses. Eliminating D requires recalling that cAMP directly connects extracellular ligand binding at GPCRs to intracellular effector activation through the adenylate cyclase–PKA cascade.